Clinical Trials
Musculoskeletal diseases tend to progress slowly and clinical trials are large and expensive
Image-based measurements and scoring methods are becoming increasingly important as surrogate primary and secondary outcomes for these clinical trials.
However, many of the image-based quantitative and semi-quantitative measurements are made manually which is time-consuming, is prone to transcription errors and may have precision problems due to subjectivity.
Automating these measurements can increase efficiency of measurement of disease progression
Optasia Medical offers workflow solutions for x-ray image analysis in MSK diseases that allow semi-automated measurement and scoring capture at the specified anatomical site. These solutions lead to better accuracy and precision in the measurement of disease state and progression reducing both trial cohort and duration.